Nes-Ziona, Israel, May 29, 2024 Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced the closing of its previously announced registered.
Enlivex Therapeutics Announces up to $15 Million Registered globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.